InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the detailed record of transactions filed by Rizvi Syed Ali-aamir, Directeur Médical. Director active across 3 companies, notably Caribou Biosciences, Inc.. Aggregated, 6 reports have been logged. Split: 0 buy · 1 sell. Total volume traded: €33k. Activity tracked since 25 January 2022. The latest transaction was disclosed on 11 February 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
Rizvi Syed Ali-aamir is Chief Medical Officer. The record shows 6 filings in total, and across the 6 sampled recent filings between 2022-01-25 and 2026-02-13, sell volume is EUR 32883 and is mainly associated with Caribou Biosciences, Inc.